Daxor Price to Sales Ratio 2010-2011 | DXR

Historical PS ratio values for Daxor (DXR) over the last 10 years. The current P/S ratio for Daxor as of July 08, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Daxor P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-07-08 9.35 27.30
2011-12-31 8.59 $0.34 25.07
2011-09-30 9.87 $0.34 29.00
2011-06-30 9.51 $0.37 25.96
2011-03-31 9.45 $0.37 25.63
2010-12-31 8.52 $0.37 22.88
2010-09-30 7.96 $0.39 20.17
2010-06-30 8.51 $0.38 22.10
2010-03-31 9.44 $0.39 24.38
2009-12-31 10.09 $0.40 25.53
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.045B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.257B 18.98
Encompass Health (EHC) United States $11.907B 25.24
DaVita (DVA) United States $10.857B 15.27
Elanco Animal Health (ELAN) United States $7.326B 15.69
Chemed (CHE) United States $6.816B 21.42
Option Care Health (OPCH) United States $5.052B 22.52
RadNet (RDNT) United States $4.151B 263.43
Amedisys (AMED) United States $3.205B 21.56
Addus HomeCare (ADUS) United States $2.062B 22.64
LifeStance Health (LFST) United States $1.839B 0.00
Astrana Health (ASTH) United States $1.372B 33.99
U.S Physical Therapy (USPH) United States $1.166B 30.10
Pennant (PNTG) United States $0.891B 32.71
Aveanna Healthcare Holdings (AVAH) United States $0.835B 47.56
Atai Life Sciences (ATAI) Germany $0.527B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00